Literature DB >> 22100854

Chikungunya: a re-emerging virus.

Felicity J Burt1, Micheal S Rolph, Nestor E Rulli, Suresh Mahalingam, Mark T Heise.   

Abstract

In the past decade, chikungunya--a virus transmitted by Aedes spp mosquitoes--has re-emerged in Africa, southern and southeastern Asia, and the Indian Ocean Islands as the cause of large outbreaks of human disease. The disease is characterised by fever, headache, myalgia, rash, and both acute and persistent arthralgia. The disease can cause severe morbidity and, since 2005, fatality. The virus is endemic to tropical regions, but the spread of Aedes albopictus into Europe and the Americas coupled with high viraemia in infected travellers returning from endemic areas increases the risk that this virus could establish itself in new endemic regions. This Seminar focuses on the re-emergence of this disease, the clinical manifestations, pathogenesis of virus-induced arthralgia, diagnostic techniques, and various treatment modalities. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22100854     DOI: 10.1016/S0140-6736(11)60281-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  210 in total

1.  Molecular characterization of chikungunya virus from three regions of Cameroon.

Authors:  Demanou Maurice; Sadeuh-Mba Serge Alain; Vanhecke Christophe; Ndikweti Rene; Kouna Tsala Irene; Inais Nsizoa Marthe; Njouom Richard
Journal:  Virol Sin       Date:  2015-12       Impact factor: 4.327

Review 2.  Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins.

Authors:  Xiao Zhang; Lu Xin; Shaowei Li; Mujin Fang; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.

Authors:  Ellen M Bouma; Denise P I van de Pol; Ilson D Sanders; Izabela A Rodenhuis-Zybert; Jolanda M Smit
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

4.  Genome-Wide Screening Uncovers the Significance of N-Sulfation of Heparan Sulfate as a Host Cell Factor for Chikungunya Virus Infection.

Authors:  Atsushi Tanaka; Uranan Tumkosit; Shota Nakamura; Daisuke Motooka; Natsuko Kishishita; Thongkoon Priengprom; Areerat Sa-Ngasang; Taroh Kinoshita; Naokazu Takeda; Yusuke Maeda
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

5.  Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.

Authors:  Haiyan Chu; Subash C Das; Jeremy F Fuchs; M Suresh; Scott C Weaver; Dan T Stinchcomb; Charalambos D Partidos; Jorge E Osorio
Journal:  Vaccine       Date:  2013-05-29       Impact factor: 3.641

6.  Fatty Acid Synthase Promotes the Palmitoylation of Chikungunya Virus nsP1.

Authors:  Na Zhang; Hongjian Zhao; Leiliang Zhang
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

7.  Local and regional spread of chikungunya fever in the Americas.

Authors:  S Cauchemez; M Ledrans; C Poletto; P Quenel; H de Valk; V Colizza; P Y Boëlle
Journal:  Euro Surveill       Date:  2014-07-17

8.  DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice.

Authors:  Irina Tretyakova; Jason Hearn; Eryu Wang; Scott Weaver; Peter Pushko
Journal:  J Infect Dis       Date:  2014-02-28       Impact factor: 5.226

9.  CD8+ T cells control Ross River virus infection in musculoskeletal tissues of infected mice.

Authors:  Kristina S Burrack; Stephanie A Montgomery; Dirk Homann; Thomas E Morrison
Journal:  J Immunol       Date:  2014-12-08       Impact factor: 5.422

10.  Chagas Disease in Southern Coastal Ecuador: Coinfections with Arboviruses and a Comparison of Serological Assays for Chagas Disease Diagnosis.

Authors:  Neida K Mita-Mendoza; Elizabeth McMahon; Aileen Kenneson; Arturo Barbachano-Guerrero; Efrain Beltran-Ayala; Cinthya Cueva; Christine A King; Christina D Lupone; Yagahira E Castro-Sesquen; Robert H Gilman; Timothy P Endy; Anna M Stewart-Ibarra
Journal:  Am J Trop Med Hyg       Date:  2018-10-18       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.